ROCKVILLE, Md. & LANGENFELD, Germany--(BUSINESS WIRE)--MEDIFACTS INTERNATIONAL, INC. one of the largest global providers of noninvasive cardiac diagnostic services today announced the award of a $1.6 million contract with a top five pharmaceutical company to provide comprehensive cardiac safety and efficacy services for a large, late-stage clinical trial.
